重复房颤消融术中标测与节律结局的性别差异
本研究分析了443例接受第二次房颤消融的患者,比较男女在标测、左房压力、并发症和长期复发上的差异。女性肺静脉重连率较低,但肺静脉外触发灶和左房压力升高更显著,且临床复发率更高。女性性别、非阵发性房颤和肺静脉外触发灶是重复术后复发的独立预测因素。
要点
- 女性重复消融时肺静脉重连率低于男性,但肺静脉外触发灶更多。
- 女性左房压升高比例更高,且术后临床复发率显著高于男性。
- 女性性别、非阵发性房颤和肺静脉外触发灶独立预测重复术后复发。
核心结论
- 重复房颤消融中,女性肺静脉重连较少,但肺静脉外触发灶和左房压升高更明显,导致节律结局较差。
研究设计与样本
- 注册研究纳入3282例患者,分析其中443例接受第二次房颤消融的连续患者(女性24.6%,年龄58.5±10.3岁,阵发性房颤61.5%),采用倾向评分匹配比较临床因素、标测、左房压力、并发症和长期复发。
主要发现
- 女性左房容积指数更高(43.1±18.6 vs 35.8±11.6 mL/m2,p<0.001),但左房内径(40.0±6.8 vs 41.6±6.3 mm,p=0.018)、左房电压(0.94±0.55 vs 1.20±0.68 mV,p=0.002)和心包脂肪体积(89.5±43.1 vs 122.1±53.9 cm3,p<0.001)更低。
- 女性肺静脉重连率更低(58.7% vs 74.9%,p=0.001),但肺静脉外触发灶比例(27.5% vs 17.0%,p=0.026)和左房脉冲压升高比例(79.7% vs 63.7%,p=0.019)更高。
- 手术相关并发症率无显著性别差异(4.6% vs 4.2%,p=0.791)。
- 中位随访31个月(8-60),女性在首次术后(log-rank p=0.039,无抗心律失常药物log-rank p<0.001)和第二次术后(log-rank p=0.006,无抗心律失常药物log-rank p=0.093)临床复发均显著更高。
- 女性性别(HR 1.51,95% CI 1.06 to 2.15,p=0.023)、非阵发性房颤(HR 1.78,95% CI 1.30 to 2.34,p<0.010)和肺静脉外触发灶(HR 1.88,95% CI 1.28 to 2.75,p=0.001)与重复术后临床复发独立相关。
临床怎么用
- 重复消融术前应关注女性患者的肺静脉外触发灶和左房压升高,以评估复发风险。
- 女性、非阵发性房颤及存在肺静脉外触发灶的患者术后需加强节律监测和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of procedure-related complications and rhythm outcomes differ between men and women after atrial fibrillation catheter ablation (AFCA). We evaluated whether consistent sex differences existed in mapping and rhythm outcomes in repeat ablation procedures. METHODS: Among 3282 patients in the registry, we analysed 443 consecutive patients (24.6% female, 58.5±10.3 years old, 61.5% with paroxysmal atrial fibrillation) who underwent a second AFCA. We compared the clinical factors, mapping, left atrial (LA) pressure, complications and long-term clinical recurrences after propensity score matching. RESULTS: LA volume index (43.1±18.6 vs 35.8±11.6 mL/m2, p<0.001) was higher, but LA dimension (40.0±6.8 vs 41.6±6.3 mm, p=0.018), LA voltage (0.94±0.55 vs 1.20±0.68 mV, p=0.002) and pericardial fat volume (89.5±43.1 vs 122.1±53.9 cm3, p<0.001) were lower in women with repeat ablation than in their male counterparts. Pulmonary vein (PV) reconnections were lower (58.7% vs 74.9%, p=0.001), but the proportion of extra-PV triggers (27.5% vs 17.0%, p=0.026) and elevated LA pulse pressures (79.7% vs 63.7%, p=0.019) was significantly higher in women than in men. There was no significant sex difference in the rate of procedure-related complications (4.6% vs 4.2%, p=0.791). During a 31-month (8-60) median follow-up, clinical recurrences were significantly higher in women after both the de novo procedure (log-rank p=0.039, antiarrhythmic drug (AAD)-free log-rank p<0.001) and the second procedure (log-rank p=0.006, AAD-free log-rank p=0.093). Female sex (HR 1.51, 95% CI 1.06 to 2.15, p=0.023), non-paroxysmal atrial fibrillation (HR 1.78, 95% CI 1.30 to 2.34, p<0.010) and extra-PV triggers (HR 1.88, 95% CI 1.28 to 2.75, p=0.001) were independently associated with clinical recurrences after repeat procedures. CONCLUSIONS: During repeat AFCA procedures, PV reconnections were lower in women than in men, and the existence of extra-PV triggers and an LA pressure elevation were more significant, which resulted in poor rhythm outcomes. TRIAL REGISTRATION NUMBER: NCT02138695.
引用
- Pak HN, Park JW, Yang SY, et al. Sex differences in mapping and rhythm outcomes of a repeat atrial fibrillation ablation. Heart. 2021. PMID: 33483352. doi:10.1136/heartjnl-2020-318282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。